Wang Z, Wu S, Chen X, Liang J, Xue F, Cho W, et al. PFKP confers chemoresistance by upregulating ABCC2 transporter in non-small cell lung cancer. Transl Lung Cancer Res. 2023;12:2294-2309 pubmed publisher

Raynard C, Ma X, Huna A, Tessier N, Massemin A, Zhu K, et al. NF-κB-dependent secretome of senescent cells can trigger neuroendocrine transdifferentiation of breast cancer cells. Aging Cell. 2022;:e13632 pubmed publisher

Yin K, Patten D, Gough S, de Barros Gonçalves S, Chan A, Olan I, et al. Senescence-induced endothelial phenotypes underpin immune-mediated senescence surveillance. Genes Dev. 2022;36:533-549 pubmed publisher

López Antona I, Contreras Jurado C, Luque Martín L, Carpintero Leyva A, González Méndez P, Palmero I. Dynamic regulation of myofibroblast phenotype in cellular senescence. Aging Cell. 2022;21:e13580 pubmed publisher

Oreskovic E, Wheeler E, Mengwasser K, Fujimura E, Martin T, Tothova Z, et al. Genetic analysis of cancer drivers reveals cohesin and CTCF as suppressors of PD-L1. Proc Natl Acad Sci U S A. 2022;119: pubmed publisher

Huang H, Lai Y, Liao C, Yang W, Huang K, Lee I, et al. Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro. EBioMedicine. 2021;74:103712 pubmed publisher

Di Giorgio E, Paluvai H, Dalla E, Ranzino L, Renzini A, Moresi V, et al. HDAC4 degradation during senescence unleashes an epigenetic program driven by AP-1/p300 at selected enhancers and super-enhancers. Genome Biol. 2021;22:129 pubmed publisher

Morel K, Hamid A, Clohessy J, Pandell N, Ellis L, Sweeney C. NF-κB Blockade with Oral Administration of Dimethylaminoparthenolide (DMAPT), Delays Prostate Cancer Resistance to Androgen Receptor (AR) Inhibition and Inhibits AR Variants. Mol Cancer Res. 2021;19:1137-1145 pubmed publisher

Huang H, Cai B, Suen C, Lee H, Hwang M, Liu F, et al. BGN/TLR4/NF-B Mediates Epigenetic Silencing of Immunosuppressive Siglec Ligands in Colon Cancer Cells. Cells. 2020;9: pubmed publisher

DeSisto J, Flannery P, Lemma R, Pathak A, Mestnik S, Philips N, et al. Exportin 1 Inhibition Induces Nerve Growth Factor Receptor Expression to Inhibit the NF-κB Pathway in Preclinical Models of Pediatric High-Grade Glioma. Mol Cancer Ther. 2020;19:540-551 pubmed publisher

Huang H, Chao C, Wu P, Chung H, Lee H, Suen C, et al. Epigenetic silencing of the synthesis of immunosuppressive Siglec ligand glycans by NF-κB/EZH2/YY1 axis in early-stage colon cancers. Biochim Biophys Acta Gene Regul Mech. 2019;1862:173-183 pubmed publisher

Yu C, Chen S, Guo Y, Sun C. Oncogenic TRIM31 confers gemcitabine resistance in pancreatic cancer via activating the NF-κB signaling pathway. Theranostics. 2018;8:3224-3236 pubmed publisher

Rodrigues P, Patel S, Harewood L, Olan I, Vojtasova E, Syafruddin S, et al. NF-κB-Dependent Lymphoid Enhancer Co-option Promotes Renal Carcinoma Metastasis. Cancer Discov. 2018;8:850-865 pubmed publisher

Yu D, Qin Y, Jun Qiang L, Shun Lin G. CNPY2 enhances resistance to apoptosis induced by cisplatin via activation of NF-?B pathway in human non-small cell lung cancer. Biomed Pharmacother. 2018;103:1658-1663 pubmed publisher

Warnier M, Flaman J, Chouabe C, Wiel C, Gras B, Griveau A, et al. The SCN9A channel and plasma membrane depolarization promote cellular senescence through Rb pathway. Aging Cell. 2018;17:e12736 pubmed publisher

He S, Niu G, Shang J, Deng Y, Wan Z, Zhang C, et al. The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-?B signaling pathway. J Exp Clin Cancer Res. 2017;36:137 pubmed publisher

Nomura A, Gupta V, Dauer P, Sharma N, Dudeja V, Merchant N, et al. NFκB-Mediated Invasiveness in CD133+ Pancreatic TICs Is Regulated by Autocrine and Paracrine Activation of IL1 Signaling. Mol Cancer Res. 2018;16:162-172 pubmed publisher

Wang L, Zhou W, Zhong Y, Huo Y, Fan P, Zhan S, et al. Overexpression of G protein-coupled receptor GPR87 promotes pancreatic cancer aggressiveness and activates NF-?B signaling pathway. Mol Cancer. 2017;16:61 pubmed publisher

Reid M, Lowman X, Pan M, Tran T, Warmoes M, Ishak Gabra M, et al. IKKβ promotes metabolic adaptation to glutamine deprivation via phosphorylation and inhibition of PFKFB3. Genes Dev. 2016;30:1837-51 pubmed publisher

Su X, Wang J, Chen W, Li Z, Fu X, Yang A. Overexpression of TRIM14 promotes tongue squamous cell carcinoma aggressiveness by activating the NF-κB signaling pathway. Oncotarget. 2016;7:9939-50 pubmed publisher

Trinh B, Barengo N, Kim S, Lee J, Zweidler McKay P, Naora H. The homeobox gene DLX4 regulates erythro-megakaryocytic differentiation by stimulating IL-1β and NF-κB signaling. J Cell Sci. 2015;128:3055-67 pubmed publisher

Xing S, Zhang B, Hua R, Tai W, Zeng Z, Xie B, et al. URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathway. BMC Cancer. 2015;15:368 pubmed publisher

Lee S, Chwee J, Ma C, Le Bert N, Huang C, Gasser S. Synergistic anticancer effects of Pam3CSK4 and Ara-C on B-cell lymphoma cells. Clin Cancer Res. 2014;20:3485-95 pubmed publisher

Flusberg D, Roux J, Spencer S, Sorger P. Cells surviving fractional killing by TRAIL exhibit transient but sustainable resistance and inflammatory phenotypes. Mol Biol Cell. 2013;24:2186-200 pubmed publisher

Robbs B, Lucena P, Viola J. The transcription factor NFAT1 induces apoptosis through cooperation with Ras/Raf/MEK/ERK pathway and upregulation of TNF-? expression. Biochim Biophys Acta. 2013;1833:2016-28 pubmed publisher

Kamran N, Takai Y, Miyoshi J, Biswas S, Wong J, Gasser S. Toll-like receptor ligands induce expression of the costimulatory molecule CD155 on antigen-presenting cells. PLoS ONE. 2013;8:e54406 pubmed publisher

Boehm J, Zhao J, Yao J, Kim S, Firestein R, Dunn I, et al. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell. 2007;129:1065-79 pubmed